ALPEK, S.A.B. de C.V.
ALPEK, S.A.B. de C.V. (ALPKF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for ALPEK, S.A.B. de C.V. (ALPKF), featuring income statements, balance sheets, and cash flow data.
ALPEK, S.A.B. de C.V. (ALPKF) Income Statement & Financial Overview
Explore comprehensive income reports for ALPEK, S.A.B. de C.V. ALPKF, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $35.02B | $34.86B | $37.16B | $33.04B |
| Cost of Revenue | $32.28B | $32.69B | $33.19B | $30.32B |
| Gross Profit | $2.74B | $2.17B | $3.97B | $2.72B |
| Gross Profit Ratio | $0.08 | $0.06 | $0.11 | $0.08 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.51B | $0.00 | $1.66B | $1.35B |
| Operating Expenses | $1.51B | $2.91B | $1.46B | $763.49M |
| Total Costs & Expenses | $33.79B | $35.60B | $34.64B | $31.09B |
| Interest Income | $78.88M | $0.00 | $32.96M | $106.36M |
| Interest Expense | $603.03M | $1.40B | $592.14M | $510.13M |
| Depreciation & Amortization | $1.31B | $0.00 | $1.19B | $1.07B |
| EBITDA | $2.38B | -$734.00M | $2.33B | $2.86B |
| EBITDA Ratio | $0.07 | -$0.02 | $0.06 | $0.09 |
| Operating Income | $1.23B | -$734.00M | $2.51B | $1.78B |
| Operating Income Ratio | $0.04 | -$0.02 | $0.07 | $0.05 |
| Other Income/Expenses (Net) | -$763.60M | -$1.40B | -$1.97B | -$1.79B |
| Income Before Tax | $469.99M | -$2.14B | $541.50M | -$6.36M |
| Income Before Tax Ratio | $0.01 | -$0.06 | $0.01 | -$0.00 |
| Income Tax Expense | $63.86M | -$627.00M | -$151.82M | -$279.58M |
| Net Income | $170.21M | -$1.60B | $483.11M | $215.55M |
| Net Income Ratio | $0.005 | -$0.05 | $0.01 | $0.007 |
| EPS | $0.08 | -$0.76 | $0.23 | $0.10 |
| Diluted EPS | $0.08 | -$0.76 | $0.23 | $0.10 |
| Weighted Avg Shares Outstanding | $2.10B | $2.11B | $2.11B | $2.11B |
| Weighted Avg Shares Outstanding (Diluted) | $2.10B | $2.11B | $2.11B | $2.11B |
Over the past four quarters, ALPEK, S.A.B. de C.V. demonstrated steady revenue growth, increasing from $33.04B in Q2 2024 to $35.02B in Q1 2025. Operating income reached $1.23B in Q1 2025, maintaining a consistent 4% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $2.38B, reflecting operational efficiency. Net income rose to $170.21M, with EPS at $0.08. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan